Form4insider filings, from the source

SEC Form 4/A · accession 0001363763-15-000009

RespireRx Pharmaceuticals Inc. · RSPI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jeff Eliot Margolis
Officer — VP, Treasurer & Secretary · Director
Period of report
Nov 5, 2014
Accepted (ET)
Aug 20, 2015 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000849636

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrants (right to buy)F2$0.035Nov 5, 2014J118,374ANov 5, 2014Sep 15, 2015Common Stock118,374118,374D
Warrants (right to buy)F2$0.035Dec 9, 2014J1,500ADec 9, 2014Sep 15, 2015Common Stock1,500119,874D
Warrants (right to buy)F2$0.035Dec 31, 2014J77,500ADec 31, 2014Sep 15, 2015Common Stock77,500197,374D
Warrants (right to buy)F2$0.035Feb 2, 2015J310,000AFeb 2, 2015Sep 15, 2015Common Stock310,000507,374D
Common Stock Options (to purchase shares of Common Stock)F2,F3$0.025Jun 30, 2015A15,000,000A—Jun 30, 2022Common Stock15,000,00015,000,000D
Common Stock Options (to purchase shares of Common Stock)F5,F4$0.05holding————Jul 17, 2019Common Stock5,000,0005,000,000D

Explanation of responses